DCOY · Decoy Therapeutics Inc. · Documents
$1.01
-0.02 (-1.94%)
At close · Oct 23
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The lack of revenue from product sales to date and recurring losses from operations since its inception raise substantial doubt as to the Company's ability to continue as a going concern.”View the 10-Q filed Aug 12, 2026
Market Cap
$674,840
Shares
655,185
Volume · Oct 22
32.1K
Avg daily vol (3M)
2.14M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| DEFA14A | — | 2021-04-27 | — | |
| 10-K | — | 2021-03-18 | 2020-12-31 | |
| 8-K | — | 2021-03-08 | — | |
| 8-K | — | 2021-03-03 | — | |
| 8-K | — | 2021-02-17 | — | |
| 8-K | — | 2021-02-05 | — | |
| 8-K | — | 2021-01-21 | — | |
| S-3 | — | 2021-01-15 | — | |
| 8-K | — | 2020-12-11 | — | |
| 8-K/A | — | 2020-12-11 | — | |
| 10-Q | — | 2020-11-12 | 2020-09-30 | |
| 8-K | — | 2020-11-12 | 2020-11-10 | |
| 8-K | — | 2020-10-06 | — | |
| 8-K | — | 2020-08-12 | — | |
| 10-Q | — | 2020-08-12 | 2020-06-30 | |
| 8-K | — | 2020-08-03 | 2020-07-29 | |
| 8-K | — | 2020-07-29 | — | |
| 8-K | — | 2020-06-19 | — | |
| 8-K | — | 2020-06-18 | — | |
| 10-Q/A | — | 2020-05-15 | 2020-03-31 | |
| 8-K | — | 2020-05-14 | 2020-03-31 | |
| 10-Q | — | 2020-05-14 | 2020-03-31 | |
| DEF 14A | — | 2020-04-29 | 2020-04-28 | |
| DEFA14A | — | 2020-04-29 | — | |
| 8-K | — | 2020-04-29 | — | |
| DEFA14A | — | 2020-04-29 | — | |
| 8-K | — | 2020-04-10 | — | |
| 8-K | — | 2020-03-27 | 2020-03-23 | |
| 10-K | — | 2020-03-23 | 2019-12-31 | |
| 8-K | — | 2020-03-11 | — | |
| 8-K | — | 2020-02-12 | 2020-02-07 | |
| S-1/A | — | 2020-02-06 | — | |
| S-1/A | — | 2020-01-28 | — | |
| S-1 | — | 2020-01-10 | — |
Showing 151–184 of 184 filings